ALT Altimmune, Inc.companySEC Filings & Insider Trading Activity 2026
Latest Altimmune, Inc. (ALT) SEC EDGAR filings in 2026, including the most recent 10-K annual report filed on March 6, 2026, a 10-Q quarterly report filed on May 13, 2026, an 8-K current report filed on July 28, 2026. SignalX aggregates every new 10-K annual report, 10-Q quarterly report, 8-K current report, and Form 4 insider transaction for Altimmune, Inc. (ALT) (SEC CIK 1326190), with AI-powered section-by-section summaries updated daily.
Latest 2026 SEC Filing Dates
Go deeper on Altimmune, Inc.
Ask AI about ALT filings. Chat with the 10-K, 10-Q, and 8-K for instant answers on financials, risks, and guidance.
Track institutional money. See which funds are building or cutting ALT positions, quarter over quarter.
Catch cross-signals. Spot when insider buying, fund accumulation, and activist stakes line up on ALT.
Recent 8-K FilingsCurrent Reports
AI-powered analysis of Altimmune, Inc. (ALT) 8-K current reports disclosing material events.
Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4
| Form | Filing Date | Period | Analysis | SEC |
|---|---|---|---|---|
8-K | Jul 28, 2026 | - | - | - |
8-K | Jun 16, 2026 | - | - | - |
10-Q | May 13, 2026 | Mar 31, 2026 | - | |
8-K | May 13, 2026 | - | - | |
8-K | Apr 24, 2026 | - | - | - |
8-K | Apr 16, 2026 | - | - | - |
10-K | Mar 6, 2026 | Dec 31, 2025 | - | |
8-K | Mar 5, 2026 | - | Analysis | - |
8-K | Feb 3, 2026 | - | - | |
8-K | Jan 28, 2026 | - | - | |
8-K | Dec 19, 2025 | - | - | |
8-K | Dec 1, 2025 | - | - | |
10-Q | Nov 6, 2025 | Sep 30, 2025 | - | |
10-Q | Aug 12, 2025 | Jun 30, 2025 | - | |
10-Q | May 13, 2025 | Mar 31, 2025 | - | |
10-K | Feb 27, 2025 | Dec 31, 2024 | - | |
10-Q | Nov 12, 2024 | Sep 30, 2024 | - | |
10-Q | Aug 8, 2024 | Jun 30, 2024 | - | |
10-Q | May 9, 2024 | Mar 31, 2024 | - | |
10-K | Mar 27, 2024 | Dec 31, 2023 | - | |
SC 13G | Mar 5, 2024 | - | - | |
SC 13G | Feb 14, 2024 | - | - | |
SC 13G | Jan 26, 2024 | - | - | |
10-Q | Nov 7, 2023 | Sep 30, 2023 | - | |
10-Q | Aug 10, 2023 | Jun 30, 2023 | - |
13F Fund Holdings: Quarterly Trend
Latest: Q1 2026Aggregate ALT share value held by 13F filers tracked by SignalX, by quarter.
- BlackRock+3.09M (+32%)
- Millennium Management+3.05M (+1471%)
- State Street Corp+2.03M (+40%)
- Two Sigma Investments+1.21M (+96%)
- Dimensional Fund Advisors+762.2K (+269%)
- Citadel Advisors LLC1.36M (-58%)
- D.E. Shaw & Co616.6K (-46%)
- Morgan Stanley584.6K (-43%)
- Wells Fargo & Co45.4K (-32%)
- Raymond James Financial2.1K (-4%)
- Coatue Management+239.3K
- Prudential Financial+21.8K
- Vanguard Group Inc−9.49M
- Invesco Ltd−214.8K
- JPMorgan Chase & Co−104.5K
- Fifth Third Bancorp−250
Source: 13F-HR filings on SEC EDGAR (aggregated from 168 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe.
Frequently Asked Questions
What are the latest ALT SEC filings in 2026?
Altimmune, Inc. (ALT) has filed a 10-K annual report on March 6, 2026, a 10-Q quarterly report on May 13, 2026, an 8-K current report on July 28, 2026 with the SEC. SignalX tracks every new SEC EDGAR filing daily, including 10-K, 10-Q, 8-K, and Form 4 insider transactions, with AI-powered summaries of key sections.
When did ALT file its most recent 10-K annual report?
Altimmune, Inc. (ALT) filed its most recent 10-K annual report on March 6, 2026. The 10-K includes audited financial statements, business overview, risk factors, and management discussion, all available on SignalX with AI-generated summaries and XBRL financial data.
How do I view ALT 10-Q quarterly reports?
Altimmune, Inc. (ALT)'s most recent 10-Q quarterly report was filed on May 13, 2026. SignalX displays every ALT 10-Q with AI-generated summaries of the MD&A (Management Discussion & Analysis) and Risk Factors sections, plus links to the original SEC EDGAR document.
What 8-K current reports has ALT filed recently?
Altimmune, Inc. (ALT)'s most recent 8-K was filed on July 28, 2026. 8-K filings disclose material corporate events such as earnings releases, executive changes, mergers, and other significant developments. SignalX surfaces each 8-K with item-level summaries so you can quickly see what happened.
Where can I find ALT insider trading activity (Form 4)?
SignalX aggregates every ALT Form 4 insider transaction from SEC EDGAR. Form 4 reports show when officers, directors, and 10% shareholders buy or sell company stock, with transaction code, share count, and price per share.
How often does ALT file with the SEC?
Altimmune, Inc. (ALT) files a 10-K annual report once per year (typically within 60 days of fiscal year-end) and 10-Q quarterly reports three times per year. 8-K current reports are filed as needed when material events occur, and Form 4 insider transaction reports are due within two business days of a trade. SignalX monitors SEC EDGAR daily to surface every new ALT filing with AI-powered analysis.
What is the difference between 10-K, 10-Q, and 8-K SEC filings?
A 10-K is a comprehensive annual report with audited financials, business overview, and risk factors. A 10-Q is a shorter quarterly report with unaudited financials and management discussion. An 8-K is a current report filed when a material event occurs, such as earnings releases, executive changes, acquisitions, or other significant developments. SignalX provides AI-generated summaries for all three filing types for Altimmune, Inc. (ALT).
What is ALT's SEC CIK number?
Altimmune, Inc. (ALT)'s SEC CIK (Central Index Key) number is 1326190. The CIK is a unique identifier assigned by the SEC to every filing entity. You can use CIK 1326190 to look up all ALT filings on SEC EDGAR, or browse them here on SignalX with AI-powered analysis.
Stay on top of Altimmune, Inc. SEC filings
Insider trading data, fund holdings, cross-signal detection, and AI-powered analysis for 109+ filings.